ONCODESIGN Secures US $4.7 Million in Financing
DIJON, France--(BUSINESS WIRE)--Oncodesign S.A, a French privately-held biotechnology company and one of the leading providers of preclinical services in Oncology, announced today a $4.7 million (Euros 3 million) financing led by new investor “Vizille Capital Innovation”. An existing investor “Avenir Entreprises” was also participating to this financing round.